Intervention

Sham electroacupuncture

ClinicalTrials.gov intervention label

Clinical trials7

Recruiting5

Common conditions13

Lead sponsors shown5

Clinical trials

7 shown

Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer SurgeryNCT07515027 · 2026-04-07

Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLCNCT07239661 · 2025-11-30

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLCNCT07086300 · 2025-07-08

Electroacupuncture Plus Antiemetic Therapy for Chemotherapy-Induced Nausea and Vomiting in Patients With Breast CancerNCT06314906 · 2024-03-07

Electroacupuncture for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients With Breast CancerNCT06200168 · 2024-01-16

Acupuncture for Anxiety/Depression in Patients With Breast CancerNCT07183813 · 2025-09-15

NOT_YET_RECRUITING

Acupuncture for Anxiety and DepressionNCT06994351 · 2025-05-18

NOT_YET_RECRUITING

Common conditions

Electroacupuncture4 Nausea and Vomiting2 Non-Small Cell Lung Cancer2 Olanzapine-contained Four-drug Antiemetic2 PD-1 Inhibitors2 Acupuncture1 Anxiety and Depression1 Anxiety Depression1 Breast Cancer1 Breast Cancer Survivor1 ECOG PS 2 Points1 Elderly Patients (>65 Years)1 PONV1

Leading sponsors

Guang'anmen Hospital of China Academy of Chinese Medical Sciences2 Kong Fanming2 Feixue Song1 Jiuda Zhao1 Shanghai Chest Hospital1

Trial status mix

RECRUITING5

NOT_YET_RECRUITING2

Phase mix

NA5

PHASE32

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.